Regression of severe fibrotic liver disease in 2 children with neonatal hemochromatosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 46, Issue 3, 2008, Pages 329-333

  Ekong, Udeme D ^a   Melin Aldana, Hector ^b   Whitington, Peter F ^a  

^a Departments of Pediatrics   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY; CASE REPORT; FEMALE; HEMOCHROMATOSIS; HOSPITALIZATION; HUMAN; INFANT; LIVER CIRRHOSIS; MALE; NEWBORN; PATHOLOGY; TIME; TREATMENT OUTCOME;

BIOPSY; FEMALE; HEMOCHROMATOSIS; HUMANS; INFANT; INFANT, NEWBORN; LIVER CIRRHOSIS; MALE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 43049178129     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318046772f     Document Type: Article

References (20)

1. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am 2003; 32:877-889.
2. Whitington PF. Fetal and infantile hemochromatosis. Hepatology 2006; 43:654-660.
3. Whitington PF, Kelly S, Ekong UD. Neonatal hemochromatosis: fetal liver disease leading to liver failure in the fetus and newborn. Pediatr Transplant 2005; 9:640-645.
4. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 2004; 364:1690-1698.
5. Silver MM, Valberg LS, Cutz E, et al. Hepatic morphology and iron quantitation in perinatal hemochromatosis. Comparison with a large perinatal control population, including cases with chronic liver disease. Am J Pathol 1993; 143:1312-1325.
6. Flynn DM, Mohan N, McKiernan P, et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed 2003; 88:F124-F127.
7. Sigurdsson L, Reyes J, Kocoshis SA, et al. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998; 26:85-89.
8. Leonis MA, Balistreri WF. Neonatal hemochromatosis: it’s OK to say “NO” to antioxidant-chelator therapy. Liver Transpl 2005; 11:1323-1325.
9. Rodrigues F, Kallas M, Nash R, et al. Neonatal hemochromatosis—medical treatment vs. transplantation: the king’s experience. Liver Transpl 2005; 11:1417-1424.
10. Anthony PP, Ishak KG, Nayak NC, et al. The morphology of cirrhosis: definition, nomenclature, and classification. Bull WHO 1977; 55:521-540.
11. Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004; 40:860-867.
12. Friedman SL, Bansal MB. Reversal of hepatic fibrosis—fact or fantasy? Hepatology 2006; 43:S82-S88.
13. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19:1409-1417.
14. Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the Pediatric Acute Liver Failure Study Group. J Pediatr 2006; 148:652-658.
15. Colletti RB, Clemmons JJ. Familial neonatal hemochromatosis with survival. J Pediatr Gastroenterol Nutr 1988; 7:39-45.
16. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-699.
17. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97:2614-2618.
18. Dufour JF, DeLellis R, Kaplan MM. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997; 127:981-985.
19. Muretto P, Angelucci E, Lucarelli G. Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation. Ann Intern Med 2002; 136:667-672.
20. Whitington PF, Malladi P. Neonatal hemochromatosis: is it an alloimmune disease? J Pediatr Gastroenterol Nutr 2005; 40:544-549.